Smart or AI In-Vitro Diagnostics Market Size, Share & Trends Analysis Report By Application Area (Cancer Diagnostics, Infectious Disease Testing, Metabolic Testing, Cardiac Testing, Diabetes Testing, and Other Disease Testing), By Technology (Next-Generation Sequencing (NGS)Technology, PCR Technology, Chemistry/IA Technology, Pathology Technology, and Other Technology), By End-User, By Region, And Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Smart or AI In-Vitro Diagnostics Market Snapshot Chapter 4. Global Smart or AI In-Vitro Diagnostics Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis 5.1. by Application & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application: 5.2.1. Cancer Diagnostics 5.2.2. Infectious Disease Testing 5.2.3. Metabolic Testing 5.2.4. Cardiac Testing 5.2.5. Diabetes Testing 5.2.6. Other Disease Testing Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis 6.1. by Technology & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology: 6.2.1. Next-Generation Sequencing (NGS) Technology 6.2.2. PCR Technology 6.2.3. Chemistry/IA Technology 6.2.4. Pathology Technology 6.2.5. Other Technology Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis 7.1. by End-user & Market Share, 2024 & 2034 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user: 7.2.1. Research 7.2.2. Pharmaceutical Research 7.2.3. Clinical Chapter 8. Smart or AI In-Vitro Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.1.2. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 8.1.3. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 8.1.4. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.2. Europe 8.2.1. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.2.2. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 8.2.3. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 8.2.4. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.3. Asia Pacific 8.3.1. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.3.2. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 8.3.3. Asia-Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 8.3.4. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.4. Latin America 8.4.1. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.4.2. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 8.4.3. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 8.4.4. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.5. Middle East & Africa 8.5.1. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034 8.5.2. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034 8.5.3. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034 8.5.4. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Adaptive Biotechnologies 9.2.2. Aidoc 9.2.3. Anumana 9.2.4. ARUP Laboratories 9.2.5. Atomwise 9.2.6. Bayesian Health 9.2.7. Behold.ai 9.2.8. BGI Genomics Co. Ltd 9.2.9. bioMérieux Diagnostics 9.2.10. Bio-Rad Laboratories, Inc 9.2.11. Cambridge Cognition 9.2.12. Cardiologs (Phillips) 9.2.13. CareDx 9.2.14. Caris Molecular Diagnostics 9.2.15. Cleerly 9.2.16. ClosedLoop AI 9.2.17. CloudMedX Health 9.2.18. Deepcell 9.2.19. Digital Diagnostics 9.2.20. EKF Diagnostics Holdings 9.2.21. Freenome 9.2.22. GE Healthcare 9.2.23. Glooko 9.2.24. Idoven 9.2.25. Illumina 9.2.26. Infohealth 9.2.27. Jade 9.2.28. K Health 9.2.29. Lunit 9.2.30. MaxCyte 9.2.31. Mayo Clinic Laboratories 9.2.32. Medtronic 9.2.33. Merative 9.2.34. Nanox 9.2.35. NIOX Group 9.2.36. Niramai Health Analytix 9.2.37. NVIDIA 9.2.38. Oncohost 9.2.39. OraLiva 9.2.40. Owkin 9.2.41. Oxford Nanopore Technologies 9.2.42. Pacific Biosciences 9.2.43. Paige.AI 9.2.44. PathAI 9.2.45. Perthera 9.2.46. Philips Healthcare 9.2.47. Prognos 9.2.48. Qiagen 9.2.49. Qure.ai 9.2.50. Renalytix 9.2.51. Seegene 9.2.52. Siemens Healthineers 9.2.53. Sophia Genetics 9.2.54. Sysmex 9.2.55. Viz.ai 9.2.56. Other Prominent Players